Rare primary non-neuroendocrine tumours of the sella

Federico Roncaroli; Chiara Villa; Debajyoti Chatterjee; Mariam Mansour; Marco Faustini-Fustini; Caterina Giannini; Kanna Gnanalingham

doi:10.1016/j.mpdhp.2018.12.001

Rare primary non-neuroendocrine tumours of the sella

Federico Roncaroli, Chiara Villa, Debajyoti Chatterjee, Mariam Mansour, Marco Faustini-Fustini, Caterina Giannini, Kanna Gnanalingham

Istituto Scienze Neurologiche

Research output: Contribution to journal › Review article › peer-review

Abstract

About 1% of primary tumour of the sellar region can be diagnostically challenging. The spectrum of these lesions includes lesions that have been codified in 4th edition of the WHO classification of tumours of the pituitary gland published in 2017 such as posterior lobe and neuronal and paraneuronal tumours as well as lesions that have not been included such as the sellar atypical teratoid rhabdoid tumour, salivary gland-like tumours and primary sellar melanocytic tumours. This review aims to provide the diagnostic criteria for these rare lesions and an overview of their essential clinical and neuroimaging features.

Original language	English
Pages (from-to)	8-15
Number of pages	8
Journal	Diagnostic Histopathology
Volume	25
Issue number	1
DOIs	https://doi.org/10.1016/j.mpdhp.2018.12.001
Publication status	Published - Jan 2019

Keywords

non-neuroendocrine tumours
pituitary gland
sella

ASJC Scopus subject areas

Pathology and Forensic Medicine
Histology

Access to Document

10.1016/j.mpdhp.2018.12.001

Fingerprint Dive into the research topics of 'Rare primary non-neuroendocrine tumours of the sella'. Together they form a unique fingerprint.

Cite this

@article{388eccff1fce4f3ab0a0af9879741d4f,

title = "Rare primary non-neuroendocrine tumours of the sella",

abstract = "About 1% of primary tumour of the sellar region can be diagnostically challenging. The spectrum of these lesions includes lesions that have been codified in 4th edition of the WHO classification of tumours of the pituitary gland published in 2017 such as posterior lobe and neuronal and paraneuronal tumours as well as lesions that have not been included such as the sellar atypical teratoid rhabdoid tumour, salivary gland-like tumours and primary sellar melanocytic tumours. This review aims to provide the diagnostic criteria for these rare lesions and an overview of their essential clinical and neuroimaging features.",

keywords = "non-neuroendocrine tumours, pituitary gland, sella",

author = "Federico Roncaroli and Chiara Villa and Debajyoti Chatterjee and Mariam Mansour and Marco Faustini-Fustini and Caterina Giannini and Kanna Gnanalingham",

note = "Richiesto CORRIGENDUM per modifica di affiliazione (inserito nel pdf della pubblicazione qui allegato). ",

year = "2019",

month = jan,

doi = "10.1016/j.mpdhp.2018.12.001",

language = "English",

volume = "25",

pages = "8--15",

journal = "Diagnostic Histopathology",

issn = "1756-2317",

publisher = "Elsevier BV",

number = "1",

}

TY - JOUR

T1 - Rare primary non-neuroendocrine tumours of the sella

AU - Roncaroli, Federico

AU - Villa, Chiara

AU - Chatterjee, Debajyoti

AU - Mansour, Mariam

AU - Faustini-Fustini, Marco

AU - Giannini, Caterina

AU - Gnanalingham, Kanna

N1 - Richiesto CORRIGENDUM per modifica di affiliazione (inserito nel pdf della pubblicazione qui allegato).

PY - 2019/1

Y1 - 2019/1

N2 - About 1% of primary tumour of the sellar region can be diagnostically challenging. The spectrum of these lesions includes lesions that have been codified in 4th edition of the WHO classification of tumours of the pituitary gland published in 2017 such as posterior lobe and neuronal and paraneuronal tumours as well as lesions that have not been included such as the sellar atypical teratoid rhabdoid tumour, salivary gland-like tumours and primary sellar melanocytic tumours. This review aims to provide the diagnostic criteria for these rare lesions and an overview of their essential clinical and neuroimaging features.

AB - About 1% of primary tumour of the sellar region can be diagnostically challenging. The spectrum of these lesions includes lesions that have been codified in 4th edition of the WHO classification of tumours of the pituitary gland published in 2017 such as posterior lobe and neuronal and paraneuronal tumours as well as lesions that have not been included such as the sellar atypical teratoid rhabdoid tumour, salivary gland-like tumours and primary sellar melanocytic tumours. This review aims to provide the diagnostic criteria for these rare lesions and an overview of their essential clinical and neuroimaging features.

KW - non-neuroendocrine tumours

KW - pituitary gland

KW - sella

UR - http://www.scopus.com/inward/record.url?scp=85058971152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058971152&partnerID=8YFLogxK

U2 - 10.1016/j.mpdhp.2018.12.001

DO - 10.1016/j.mpdhp.2018.12.001

M3 - Review article

AN - SCOPUS:85058971152

VL - 25

SP - 8

EP - 15

JO - Diagnostic Histopathology

JF - Diagnostic Histopathology

SN - 1756-2317

IS - 1

ER -